360 related articles for article (PubMed ID: 24106037)
1. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
3. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
[TBL] [Abstract][Full Text] [Related]
4. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
[TBL] [Abstract][Full Text] [Related]
5. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008.
Ettorre GM; Piselli P; Galatioto L; Rendina M; Nudo F; Sforza D; Miglioresi L; Fantola G; Cimaglia C; Vennarecci G; Vizzini GB; Di Leo A; Rossi M; Tisone G; Zamboni F; Santoro R; Agresta A; Puro V; Serraino D
Transplant Proc; 2013 Sep; 45(7):2729-32. PubMed ID: 24034034
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
Kellerman L; Neugut A; Burke B; Mancini D
Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
[TBL] [Abstract][Full Text] [Related]
10. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
11. De novo tumors are a major cause of late mortality after orthotopic liver transplantation.
Baccarani U; Adani GL; Serraino D; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; Piselli P; De Paoli A; Bresadola V; Risaliti A; Toniutto P; Cillo U; Bresadola F; Burra P
Transplant Proc; 2009 May; 41(4):1303-5. PubMed ID: 19460546
[TBL] [Abstract][Full Text] [Related]
12. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
14. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
15. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
17. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
19. De novo malignancies following liver transplantation: impact and recommendations.
Herrero JI
Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
